SCHEMBL24642917

SCHEMBL24642917

CCCCN(CCCC)CCCC[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 2/20 0.48
▸ DPP8 Q6V1X1 2/20 0.48
▸ DPP9 Q86TI2 2/20 0.48
▸ DPP7 Q9UHL4 2/20 0.48
▸ NOD1 Q9Y239 10/20 0.43
▸ MME P08473 2/20 0.43
▸ SLC6A5 Q9Y345 1/20 0.38
▸ KDM5A P29375 2/20 0.38
▸ CPB2 Q96IY4 1/20 0.37
▸ GNPAT O15228 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ FAP Q12884 1/20 0.36
▸ PHF8 Q9UPP1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26528469 0.95 DPP4 (0.45) DPP4DPP8DPP9DPP7NOD1
SCHEMBL24642680 0.90 DPP4 (0.43) DPP4DPP8DPP9DPP7NOD1
SCHEMBL29476460 0.87 DPP8 (0.60) DPP4DPP8DPP9DPP7NOD1
SCHEMBL31720381 0.86 DPP4 (0.45) DPP4DPP8DPP9DPP7NOD1
SCHEMBL24642916 0.85 DPP4 (0.41) DPP4DPP8DPP9DPP7NOD1
SCHEMBL31326452 0.82 DPP4 (0.40) DPP4DPP8DPP9DPP7NOD1
SCHEMBL6678282 0.82 DPP8 (0.55) DPP4DPP8DPP9DPP7NOD1
SCHEMBL8616850 0.82 DPP8 (0.55) DPP4DPP8DPP9DPP7NOD1
SCHEMBL8492399 0.81 DPP4 (0.51) DPP4DPP8DPP9DPP7NOD1
SCHEMBL31720380 0.81 DPP4 (0.42) DPP4DPP8DPP9DPP7NOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4257154-A1 BIOACTIVE SUBSTANCE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF Medilink Therapeutics (Suzhou) Co., Ltd. (CN) 2023-10-11 — — EP disclosed
WO-2022170971-A1 BIOACTIVE SUBSTANCE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF 苏州宜联生物医药有限公司 2022-08-18 — — WO disclosed
Send feedback